Estraderm combined with Provera

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Progesterone Receptor Assay Positive Other Serious 11/7/1996 67 Female 12/30/2005 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 9/27/1993 76 Female 12/30/2005 United States
Primary
Secondary
Stress Required Intervention 7/10/2000 62 Female 144 lb 1/13/2006 Physician United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 1/1/1996 Female 1/20/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 5/20/1992 67 Female 1/20/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/1/1996 Female 1/27/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 1/31/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 2/6/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/16/2001 49 Female 125 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/1/2002 55 Female 175 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1977 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/25/1999 60 Female 12/23/2005 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 9/1/1999 Female 2/6/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/21/1999 74 Female 2/7/2006 United States
Primary
Secondary
Breast Cancer Hospitalization 1/1/2003 Female 12/23/2005 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 9/1/1999 61 Female 2/8/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 8/20/2002 56 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 2/18/2003 66 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/26/2001 69 Female 210 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 3/31/1999 58 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/25/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2000 50 Female 160 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/18/2002 Female 12/23/2005 United States
Primary
Secondary
Stress Required Intervention 7/10/2000 62 Female 144 lb 2/21/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/1/1998 42 Female 170 lb 3/7/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 7/17/2001 73 Female 3/3/2006 United States
Primary
Secondary
Stress Required Intervention 7/10/2000 62 Female 144 lb 3/6/2006 Physician United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 10/11/1996 65 Female 3/6/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 2/20/2002 Female 3/7/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/16/2003 60 Female 189 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 11/14/2001 70 Female 135 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 7/17/1989 75 Female 3/14/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 10/8/1997 60 Female 3/17/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/3/1996 68 Female 3/27/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/1/2002 67 Female 3/23/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 8/16/2002 67 Female 3/28/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 12/3/1996 68 Female 3/28/2006 Lawyer United States
Primary
Secondary
Stress Required Intervention 7/10/2000 62 Female 144 lb 4/7/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 10/1/2001 Female 2/8/2006 Consumer United States
Primary
Secondary
Urinary Tract Infection Other Serious 1/1/1999 63 Female 181 lb 4/20/2006 Physician United States
Primary
Concomitant
Neoplasm Malignant Other Serious 12/14/1995 54 Female 190 lb 4/18/2006 Physician United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Required Intervention 7/10/2000 62 Female 144 lb 5/3/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 5/18/2004 Female 5/5/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/26/2001 73 Female 5/24/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 2/1/2004 61 Female 5/23/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 2/1/2004 63 Female 5/24/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 10/24/1994 67 Female 5/24/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 6/26/2001 73 Female 5/24/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 4/1/2002 Female 5/30/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 8/1/2004 65 Female 5/30/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 6/8/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 8/1/2004 63 Female 6/9/2006 Lawyer United States
Primary
Secondary
Ultrasound Scan Abnormal Other Serious 11/20/2002 48 Female 148 lb 6/12/2006 Physician United States
Primary
Secondary
Concomitant
Scar Other Serious 1/1/2000 61 Female 138 lb 6/14/2006 Lawyer United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Required Intervention 7/10/2000 62 Female 144 lb 6/16/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 4/1/2002 66 Female 6/26/2006 United States
Primary
Secondary
Nerve Injury Other Serious 12/19/2001 61 Female 130 lb 7/5/2006 Lawyer United States
Primary
Secondary
Concomitant
Scar Other Serious 1/1/1999 55 Female 157 lb 7/11/2006 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/1/2000 Female 7/12/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2000 Female 7/17/2006 United States
Primary
Secondary
Scar Other Serious 1/1/2000 61 Female 138 lb 8/15/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer In Situ Other Serious 12/1/1999 Female 8/30/2006 United States
Primary
Secondary
Scar Other Serious 7/17/1997 55 Female 157 lb 9/20/2006 Physician United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 7/1/2002 63 Female 150 lb 10/13/2006 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 11/1/2000 Female 11/14/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 12/1/2002 Female 12/15/2006 Lawyer United States
Primary
Secondary
Mastectomy Other Serious Female 8/31/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 8/1/2004 65 Female 8/31/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 8/9/1994 57 Female 125 lb 10/10/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 10/8/1997 60 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/28/1999 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 2/20/2002 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 7/17/2001 69 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2004 61 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/24/1994 56 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 12/3/1996 68 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1996 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 7/17/1989 75 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/15/2000 67 Female 155 lb 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/16/1996 49 Female 153 lb 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/7/1999 51 Female 10/10/2006 United States
Primary
Secondary
Physical Disability Other Serious 1/1/1997 Female 9/18/2006 Lawyer United States
Primary
Secondary
Physical Disability Other Serious 1/1/1996 Female 9/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2002 66 Female 9/18/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 7/6/1999 67 Female 9/18/2006 Lawyer United States
Primary
Secondary
Malignant Breast Lump Removal Other Serious 1/1/1999 61 Female 9/18/2006 Lawyer United States
Primary
Secondary
Breast Lump Removal Other Serious 1/3/2006 Female 9/18/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 7/17/2001 73 Female 9/18/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 10/11/1996 65 Female 9/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 2/20/2002 Female 9/18/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 7/17/1989 75 Female 9/18/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 10/8/1987 60 Female 9/18/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 8/16/2002 67 Female 9/18/2006 Lawyer United States
Primary
Secondary
Scar Other Serious 3/31/1999 64 Female 9/18/2006 Lawyer United States
Primary
Secondary
Scar Other Serious Female 9/18/2006 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 9/25/2003 Female 9/18/2006 Lawyer United States
Primary
Secondary
Scar Other Serious Female 9/18/2006 Lawyer United States
Primary
Secondary
Injury Other Serious 10/1/2002 Female 9/18/2006 Lawyer United States
Primary
Secondary
Pain Other Serious 9/19/2002 Female 9/18/2006 Lawyer United States
Primary
Secondary
Injury Other Serious 10/1/2001 Female 9/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 5/18/2004 60 Female 9/18/2006 Lawyer United States
Primary
Secondary
Mastectomy Other Serious 12/23/1999 Female 9/18/2006 Lawyer United States
Primary
Secondary
Radiotherapy Other Serious 2/1/2000 63 Female 9/18/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 10/24/1994 67 Female 9/18/2006 Lawyer United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 6/26/2001 73 Female 9/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 9/18/2006 Lawyer United States
Primary
Secondary
Injury Other Serious 10/28/1999 9/18/2006 Lawyer United States
Primary
Secondary
Injury Other Serious 9/27/1993 76 Female 9/18/2006 Lawyer United States
Primary
Secondary
Injury Other Serious 11/7/1996 67 Female 9/18/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 5/20/1992 67 Female 9/18/2006 Lawyer United States
Primary
Secondary
Vulvovaginal Mycotic Infection Other Serious 1/1/1995 51 Female 170 lb 2/28/2007 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 1/1/1995 Female 2/28/2007 United States
Primary
Secondary
Concomitant
Thalamotomy Other Serious 1/1/1995 75 Female 130 lb 3/1/2007 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 1/15/1999 67 Female 138 lb 3/1/2007 United States
Primary
Secondary
Concomitant
Tenderness Other Serious 10/1/1994 53 Female 136 lb 3/1/2007 United States
Primary
Secondary
Concomitant
Tachycardia Other Serious 8/9/1994 57 Female 125 lb 3/1/2007 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 1/15/1999 67 Female 138 lb 3/1/2007 United States
Primary
Secondary
Concomitant
Visual Disturbance Other Serious 1/1/1998 55 Female 3/1/2007 United States
Primary
Secondary
Concomitant
Tenderness Other Serious 1/1/1998 65 Female 130 lb 3/9/2007 United States
Primary
Secondary
Concomitant
Venous Insufficiency Other Serious 8/15/1999 54 Female 118 lb 3/17/2007
Primary
Secondary
Germ Cell Cancer Hospitalization 7/12/2006 16 Female 101 lb 3/26/2007 Physician Japan
Primary
Concomitant
Tendinous Contracture Other Serious 1/1/1984 49 Female 160 lb 3/23/2007 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 1/1/1995 51 Female 3/27/2007 United States
Primary
Secondary
Vaginal Infection Other Serious 2/1/1993 59 Female 212 lb 3/27/2007 United States
Primary
Secondary
Concomitant
Vulvar Dysplasia Other Serious 1/1/1993 62 Female 169 lb 3/29/2007 United States
Primary
Secondary
Concomitant
Ultrasound Breast Abnormal Other Serious 1/1/2000 60 Female 180 lb 3/28/2007 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious Female 11/3/2006 Lawyer United States
Primary
Secondary
Wound Necrosis Other Serious 2/19/2001 58 Female 112 lb 4/5/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 4/1/2002 66 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1997 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 10/11/1996 56 Female 12/22/2006 United States
Primary
Secondary
Germ Cell Cancer Hospitalization 7/12/2006 16 Female 101 lb 4/9/2007 Physician Japan
Primary
Concomitant
Breast Cancer Other Serious 5/18/2004 59 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/7/1996 58 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/26/2001 73 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/20/1999 54 Female 162 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/25/2003 72 Female 157 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/20/2002 54 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2002 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/16/2002 67 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2000 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 12/22/2006 United States
Primary
Secondary
Weight Increased Other Serious 8/5/1994 56 Female 130 lb 4/14/2007 United States
Primary
Secondary
Concomitant
Wheelchair User Other Serious 1/28/1992 58 Female 160 lb 4/14/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/1/2002 Female 1/31/2007 Consumer United States
Primary
Secondary

Drug Data